Company
CFO
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Andrew Hindman has spoken on 11 earnings calls across 1 company, most recently on November 7, 2022.
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
Organization not stated
CFO
Proxy statement
Start not stated–2022-03-25
Last confirmed by a filing; no departure on record
Recorded roles and call appearances connecting this person to public companies.
Company
CFO
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
Theravance Biopharma, Inc. Q3 FY2022 Earnings Call
Theravance Biopharma, Inc. Q2 FY2022 Earnings Call
Theravance Biopharma, Inc. Q1 FY2022 Earnings Call
Theravance Biopharma, Inc. Q4 FY2021 Earnings Call
Theravance Biopharma, Inc. Q3 FY2021 Earnings Call
Theravance Biopharma, Inc. Q2 FY2021 Earnings Call
Theravance Biopharma, Inc. Q1 FY2021 Earnings Call
Theravance Biopharma, Inc. Q4 FY2020 Earnings Call
Theravance Biopharma, Inc. Q3 FY2020 Earnings Call
Theravance Biopharma, Inc. Q2 FY2020 Earnings Call
Theravance Biopharma, Inc. Q1 FY2020 Earnings Call